Klahr Saulo
Department of Medicine, Washington University School of Medicine, Barnes-Jewish Hospital, 216 S. Kingshighway Boulevard, St. Louis, MO 63110-1092, USA.
J Nephrol. 2003 Mar-Apr;16(2):179-85.
Recently, a protein has emerged as a potential renotrophic factor: bone morphogenetic protein-7 (BMP-7). In a preventive protocol, BMP-7 treatment was found to significantly decrease renal injury in a rat model of ureteral obstruction (UUO), when treatment was initiated at the time of injury. Subsequent studies suggested that BMP-7 treatment also attenuated renal fibrosis when administered after renal fibrosis had begun. This treatment protocol was also found to increase significantly renal function from the levels measured in the vehicle-treated group. BMP-7 also partially reversed the diabetic nephropathy induced in rats by a single dose of streptozotocin. It restored glomerular filtration rate (GFR), decreased the excretion of protein, and restored histology towards normal. These studies also highlight the value of histological parameters as indicators of renal function and the potential of renal homeostatic factors in the treatment of kidney disease.
最近,一种蛋白质已成为一种潜在的促肾营养因子:骨形态发生蛋白-7(BMP-7)。在一项预防性方案中,当在损伤时开始治疗时,发现BMP-7治疗可显著降低输尿管梗阻(UUO)大鼠模型中的肾损伤。随后的研究表明,在肾纤维化开始后给予BMP-7治疗也可减轻肾纤维化。还发现该治疗方案可使肾功能较载体治疗组所测水平显著提高。BMP-7还部分逆转了单次注射链脲佐菌素诱导的大鼠糖尿病肾病。它恢复了肾小球滤过率(GFR),减少了蛋白质排泄,并使组织学恢复正常。这些研究还强调了组织学参数作为肾功能指标的价值以及肾稳态因子在治疗肾脏疾病方面的潜力。